PET/CT for Ovarian Cancer

Last Modified: July 14, 2007


Dear OncoLink "Ask The Experts,"

I was diagnosed with fallopian cancer January 2006 had surgery and 6 chemo treatments ending July 2006. My Gynecologic Oncologist ordered a PET/CT in February 2007. My insurance company is refusing to pay for the scan saying it is not a proven for my type of cancer. I'm looking for research data that will support the use of PET/CT in fallopian/ovarian cancer.


Stephen C. Rubin, MD, Professor and Chief of the Division of Gynecologic Oncology, University of Pennsylvania Health System, responds:

At present, there is no convincing data that using PET/CT scans will improve the outcome for women with ovarian cancer. In other words, finding recurrence on a PET/CT when no symptoms are present (pain, elevated CA-125, etc) may not result in any improvement in survival. This was found to be true in breast cancer and guidelines state that those patients should have radiology scans (CT, bone scans, etc) only if symptoms arise. Many insurance companies will not pay for the PET/CT test, as it is quite expensive and there is a fair amount of uncertainty as to its value in improving patient outcomes.


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Tattoos Can Mimic Metastasis on PET-CT in Cervical Cancer

Jun 15, 2015

Case report describes woman with extensive tattoos who had nodes ID'd as suspicious for metastases

Bone Marrow Biopsy Adds Little to PET/CT Staging of Hodgkin's

Nov 15, 2012

Absence of positive bone marrow biopsy for patients with PET/CT-assessed stage I, II disease

PET-CT Rarely Impacts Surgical Management of CRC Metastases

May 14, 2014

Use of PET-CT versus CT has little impact for patients with potentially resectable hepatic mets